• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

化疗药物对人类有机阴离子转运体hOAT4的抑制作用。

Inhibitory effects of chemotherapeutics on human organic anion transporter hOAT4.

作者信息

Toh May Fern, Suh Wonmo, Wang Haoxun, Zhou Peter, Hu Longqin, You Guofeng

机构信息

Departments of Pharmaceutics and Medicinal Chemistry, Ernest Mario School of Pharmacy, Rutgers University NJ, USA.

出版信息

Int J Biochem Mol Biol. 2016 Jun 1;7(1):11-8. eCollection 2016.

PMID:27335682
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4913227/
Abstract

Human organic anion transporter 4 (hOAT4) belongs to a family of organic anion transporters which play critical roles in the body disposition of clinically important drugs. hOAT4 is expressed in the kidney and placenta. In the current study, we examined the inhibitory effects of 101 anticancer drugs from a clinical drug library on hOAT4 transport activity. The studies were carried out in hOAT4-expressing human kidney HEK-293 cells and human placenta BeWo cells. Among these drugs, only chlorambucil and cabazitaxel demonstrated more than 50% cis-inhibitory effect on hOAT4-mediated uptake of (3)H-labeled estrone sulfate, a prototypical substrate for the transporter. The IC50 values for chlorambucil and cabazitaxel were 44.28 and 3.5 µM respectively. Dixon plot analysis revealed that inhibition by chlorambucil was competitive with a Ki = 55.73 µM whereas inhibition by cabazitaxel was non-competitive with a Ki = 1.78 µM. Our results demonstrated that chlorambucil and cabazitaxel were inhibitors of hOAT4. Furthermore, by comparing our data with clinically relevant exposures of these drugs, we conclude that the propensity for chlorambucil and cabazitaxel to cause drug-drug interaction through inhibition of hOAT4 is low.

摘要

人有机阴离子转运体4(hOAT4)属于有机阴离子转运体家族,该家族在临床上重要药物的体内处置过程中发挥着关键作用。hOAT4在肾脏和胎盘中表达。在本研究中,我们检测了临床药物库中101种抗癌药物对hOAT4转运活性的抑制作用。研究在表达hOAT4的人肾HEK - 293细胞和人胎盘BeWo细胞中进行。在这些药物中,只有苯丁酸氮芥和卡巴他赛对hOAT4介导的原型底物(3)H标记硫酸雌酮摄取表现出超过50%的顺式抑制作用。苯丁酸氮芥和卡巴他赛的IC50值分别为44.28和3.5 μM。Dixon作图分析表明,苯丁酸氮芥的抑制作用具有竞争性,Ki = 55.73 μM,而卡巴他赛的抑制作用为非竞争性,Ki = 1.78 μM。我们的结果表明苯丁酸氮芥和卡巴他赛是hOAT4的抑制剂。此外,通过将我们的数据与这些药物的临床相关暴露情况进行比较,我们得出结论,苯丁酸氮芥和卡巴他赛通过抑制hOAT4导致药物相互作用的倾向较低。

相似文献

1
Inhibitory effects of chemotherapeutics on human organic anion transporter hOAT4.化疗药物对人类有机阴离子转运体hOAT4的抑制作用。
Int J Biochem Mol Biol. 2016 Jun 1;7(1):11-8. eCollection 2016.
2
Interaction of Anticancer Drugs with Human Organic Anion Transporter hOAT4.抗癌药物与人类有机阴离子转运蛋白hOAT4的相互作用。
J Oncol. 2019 Feb 28;2019:1951786. doi: 10.1155/2019/1951786. eCollection 2019.
3
Functional characterization of a human organic anion transporter hOAT4 in placental BeWo cells.人有机阴离子转运体hOAT4在胎盘BeWo细胞中的功能特性研究
Eur J Pharm Sci. 2006 Apr;27(5):518-23. doi: 10.1016/j.ejps.2005.09.008. Epub 2005 Oct 27.
4
Regulation of human organic anion transporter 4 by progesterone and protein kinase C in human placental BeWo cells.孕酮和蛋白激酶C对人胎盘BeWo细胞中人类有机阴离子转运体4的调控
Am J Physiol Endocrinol Metab. 2007 Jul;293(1):E57-61. doi: 10.1152/ajpendo.00696.2006. Epub 2007 Mar 6.
5
Serum- and glucocorticoid-inducible kinase SGK2 regulates human organic anion transporters 4 via ubiquitin ligase Nedd4-2.血清和糖皮质激素诱导激酶SGK2通过泛素连接酶Nedd4-2调节人类有机阴离子转运体4。
Biochem Pharmacol. 2016 Feb 15;102:120-129. doi: 10.1016/j.bcp.2015.11.024. Epub 2015 Dec 29.
6
Regulation of human organic anion transporter 4 by parathyroid hormone-related protein and protein kinase A.甲状旁腺激素相关蛋白和蛋白激酶A对人类有机阴离子转运体4的调控
Int J Biochem Mol Biol. 2012;3(3):322-7. Epub 2012 Sep 25.
7
Comparison of the interaction of human organic anion transporter hOAT4 with PDZ proteins between kidney cells and placental cells.人有机阴离子转运体hOAT4与肾脏细胞和胎盘细胞中PDZ蛋白相互作用的比较。
Pharm Res. 2008 Feb;25(2):475-80. doi: 10.1007/s11095-007-9359-4. Epub 2007 Jun 30.
8
Human renal organic anion transporter 4 operates as an asymmetric urate transporter.人类肾脏有机阴离子转运体4作为一种不对称尿酸转运体发挥作用。
J Am Soc Nephrol. 2007 Feb;18(2):430-9. doi: 10.1681/ASN.2006040415. Epub 2007 Jan 17.
9
Interaction of human organic anion transporters 2 and 4 with organic anion transport inhibitors.人类有机阴离子转运体2和4与有机阴离子转运抑制剂的相互作用。
J Pharmacol Exp Ther. 2002 Jun;301(3):797-802. doi: 10.1124/jpet.301.3.797.
10
The mechanistic links between insulin and human organic anion transporter 4.胰岛素与人类有机阴离子转运蛋白 4 之间的机制联系。
Int J Pharm. 2019 Jan 30;555:165-174. doi: 10.1016/j.ijpharm.2018.11.040. Epub 2018 Nov 16.

引用本文的文献

1
Chloroquine and Hydroxychloroquine, as Proteasome Inhibitors, Upregulate the Expression and Activity of Organic Anion Transporter 3.氯喹和羟氯喹作为蛋白酶体抑制剂,上调有机阴离子转运体3的表达和活性。
Pharmaceutics. 2023 Jun 14;15(6):1725. doi: 10.3390/pharmaceutics15061725.
2
Isotretinoin and its Metabolites Alter mRNA of Multiple Enzyme and Transporter Genes In Vitro, but Downregulation of Organic Anion Transporting Polypeptide Does Not Translate to the Clinic.异维 A 酸及其代谢物在体外改变多种酶和转运体基因的 mRNA,但有机阴离子转运多肽的下调并未转化为临床。
Drug Metab Dispos. 2022 Jul;50(7):1042-1052. doi: 10.1124/dmd.122.000882. Epub 2022 May 11.
3
Review of Transporter Substrate, Inhibitor, and Inducer Characteristics of Cladribine.克拉屈滨的转运体底物、抑制剂和诱导剂特性综述。
Clin Pharmacokinet. 2021 Dec;60(12):1509-1535. doi: 10.1007/s40262-021-01065-3. Epub 2021 Aug 26.
4
Regulation of organic anion transporters: Role in physiology, pathophysiology, and drug elimination.有机阴离子转运体的调节:在生理学、病理生理学和药物消除中的作用。
Pharmacol Ther. 2021 Jan;217:107647. doi: 10.1016/j.pharmthera.2020.107647. Epub 2020 Aug 3.
5
Interaction of Anticancer Drugs with Human Organic Anion Transporter hOAT4.抗癌药物与人类有机阴离子转运蛋白hOAT4的相互作用。
J Oncol. 2019 Feb 28;2019:1951786. doi: 10.1155/2019/1951786. eCollection 2019.

本文引用的文献

1
Renal human organic anion transporter 3 increases the susceptibility of lymphoma cells to bendamustine uptake.人肾有机阴离子转运体3增加淋巴瘤细胞对苯达莫司汀摄取的敏感性。
Am J Physiol Renal Physiol. 2015 Feb 15;308(4):F330-8. doi: 10.1152/ajprenal.00467.2014. Epub 2014 Dec 4.
2
Identification of an allosteric modulator of the serotonin transporter with novel mechanism of action.鉴定具有新型作用机制的 5-羟色胺转运体别构调节剂。
Neuropharmacology. 2013 Sep;72:282-90. doi: 10.1016/j.neuropharm.2013.04.026. Epub 2013 Apr 28.
3
Potent inhibitors of human organic anion transporters 1 and 3 from clinical drug libraries: discovery and molecular characterization.从临床药物库中发现并鉴定对人有机阴离子转运蛋白 1 和 3 具有强抑制作用的化合物。
Mol Pharm. 2012 Nov 5;9(11):3340-6. doi: 10.1021/mp300365t. Epub 2012 Sep 25.
4
Drug transport by Organic Anion Transporters (OATs).有机阴离子转运体(OATs)介导的药物转运。
Pharmacol Ther. 2012 Oct;136(1):106-30. doi: 10.1016/j.pharmthera.2012.07.010. Epub 2012 Jul 25.
5
Contribution of tumoral and host solute carriers to clinical drug response.肿瘤和宿主溶质载体对临床药物反应的贡献。
Drug Resist Updat. 2012 Feb-Apr;15(1-2):5-20. doi: 10.1016/j.drup.2012.01.009. Epub 2012 Mar 28.
6
OATPs, OATs and OCTs: the organic anion and cation transporters of the SLCO and SLC22A gene superfamilies.OATPs、OATs 和 OCTs:SLCO 和 SLC22A 基因超家族的有机阴离子和阳离子转运体。
Br J Pharmacol. 2012 Mar;165(5):1260-87. doi: 10.1111/j.1476-5381.2011.01724.x.
7
Cabazitaxel: a novel second-line treatment for metastatic castration-resistant prostate cancer.卡巴他赛:转移性去势抵抗性前列腺癌的新型二线治疗药物。
Drug Des Devel Ther. 2011 Mar 10;5:117-24. doi: 10.2147/DDDT.S13029.
8
Membrane transporters in drug development.药物开发中的膜转运体。
Nat Rev Drug Discov. 2010 Mar;9(3):215-36. doi: 10.1038/nrd3028.
9
Probenecid, an inhibitor of transmembrane organic anion transporters, alters tissue distribution of DNA adducts in 1-hydroxymethylpyrene-treated rats.丙磺舒是一种跨膜有机阴离子转运体抑制剂,可改变1-羟基芘处理大鼠体内DNA加合物的组织分布。
Toxicology. 2009 Jul 28;262(1):80-5. doi: 10.1016/j.tox.2009.05.016. Epub 2009 May 27.
10
Novobiocin is a potent inhibitor for human organic anion transporters.新生霉素是一种强效的人类有机阴离子转运体抑制剂。
Drug Metab Dispos. 2009 Jun;37(6):1203-10. doi: 10.1124/dmd.109.026880. Epub 2009 Mar 12.